Editorials The impact of sleep quality on the prognosis of inflammatory bowel disease commonly overlooked by gastroenterologists

Ji Young Chang

Intest Res. 2024;22(1):5-7.

A novel serum biomarker of endoscopic mucosal healing in inflammatory bowel disease

Hyoun Woo Kang

Intest Res. 2024;22(1):3-4.

Which biomarkers best reflect the degree of inflammation in Crohn’s disease?

Jihye Park

Intest Res. 2024;22(1):1-2.

To overcome medical gap in screening and surveillance of colorectal cancer during the COVID-19 pandemic

Yoo Min Han

Intest Res. 2023;21(4):418-419.

Not all acute colonic diverticulitis follows the same course: a potential risk for immunocompromised individuals

Yehyun Park

Intest Res. 2023;21(4):415-417.

Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease

Kwang Woo Kim, Hyoun Woo Kang

Intest Res. 2023;21(4):413-414.

Beyond the survey, to the ideal therapy for Asian

Ki Jae Jo, Jong Pil Im

Intest Res. 2023;21(3):280-282.

Diagnosis, management, and prevention of infectious complications in inflammatory bowel disease: variations among Asian countries

Ji Eun Baek, Sung Wook Hwang

Intest Res. 2023;21(3):277-279.

How have treatment patterns for patients with inflammatory bowel disease changed in Asian countries?

Jihye Park

Intest Res. 2023;21(3):275-276.

Are the risks of colorectal cancer and biliary cancer really increased if patients with ulcerative colitis have primary sclerosing cholangitis?

Jung Wook Lee, Won Moon

Intest Res. 2023;21(2):171-173.

Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education

Seulji Kim, Seong-Joon Koh

Intest Res. 2022;20(4):389-391.

Prevention of postoperative recurrence in Crohn’s disease: the never-ending story

Jung-Bin Park, Sang Hyoung Park

Intest Res. 2022;20(3):279-280.

Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?

Yong Eun Park

Intest Res. 2022;20(2):157-158.

Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?

Jihye Park

Intest Res. 2022;20(1):1-2.

Does cytomegalovirus load predict the outcome of acute severe ulcerative colitis?

You Sun Kim

Intest Res. 2021;19(4):357-359.

The first step to unveil the epidemiology of inflammatory bowel disease in Central Asia

Seung Wook Hong, Byong Duk Ye

Intest Res. 2020;18(4):345-346.

Education levels and survival in colorectal cancer: is there really an obvious association?

Bruna Valiati, Rodrigo Oliva Perez, Paulo Gustavo Kotze

Intest Res. 2020;18(3):247-248.

Tumor necrosis factor-α inhibitor use in patients with malignancy: is it safe?

Gyu Man Oh, Won Moon

Intest Res. 2020;18(3):245-246.

Complementary and alternative medicine in patients with inflammatory bowel disease: hype or evidence?

Jae Myung Cha

Intest Res. 2020;18(2):141-143.

Enteral nutrition in the biologic era: learn from yesterday, live for today, hope for tomorrow

Tadakazu Hisamatsu

Intest Res. 2020;18(2):139-140.

Tacrolimus in pediatric ulcerative colitis: does it have a role?

Seung Kim

Intest Res. 2019;17(4):441-442.

Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis

Hyuk Yoon

Intest Res. 2019;17(3):283-284.

Can vitamin D supplementation help control inflammation in inflammatory bowel disease beyond its classical role in bone health?

Sung Wook Hwang

Intest Res. 2019;17(2):157-159.

Multi-session fecal microbiota transplantation using colonoscopy has favorable outcomes for the treatment of steroid-dependent ulcerative colitis

Young-Seok Cho

Intest Res. 2019;17(1):6-8.

Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases

Young-Ho Kim

Intest Res. 2018;16(4):507-508.

The importance of immunization in immune-mediated inflammatory disease cannot be overstated

Sang Hyoung Park

Intest Res. 2018;16(3):325-326.

Can water insufflation and carbon dioxide overcome the difficulties of colonoscope insertion?

Choong-Kyun Noh, Kee Myung Lee

Intest Res. 2018;16(2):166-167.

Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?

Seong Ran Jeon

Intest Res. 2018;16(2):163-165.

Can histologic remission be a better prognostic factor and therapeutic target beyond endoscopic mucosal healing in patients with ulcerative colitis?

Hyo Jun Ahn, Sang-Bum Kang

Intest Res. 2018;16(1):1-3.

Role of capsule endoscopy in suspected or established Crohn's disease in real practice

Hyun Joo Jang

Intest Res. 2017;15(4):431-433.

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?

Jihye Park, Jae Hee Cheon

Intest Res. 2017;15(3):263-265.

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

Jong Pil Im

Intest Res. 2017;15(2):147-148.

Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?

Chang Soo Eun

Intest Res. 2017;15(2):145-146.

Inflammatory bowel disease is no longer a risk factor of viral hepatitis infection in Asia

Eun Soo Kim

Intest Res. 2017;15(1):5-6.

Can narrow-band imaging of Peyer's patches predict the recurrence of ulcerative colitis?

Yoon Jae Kim

Intest Res. 2016;14(4):295-296.

Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?

Shu Chen Wei

Intest Res. 2016;14(4):293-294.

Results of the first survey for the current status of inflammatory bowel disease management in Asian countries

Ji Won Kim

Intest Res. 2016;14(3):199-201.

Micronutrient deficiencies in inflammatory bowel disease: trivial or crucial?

Soon Man Yoon

Intest Res. 2016;14(2):109-110.

Concerns in pregnancy and childbirth of women with inflammatory bowel disease

Sung-Ae Jung

Intest Res. 2016;14(2):107-108.

Are there interregional differences in the epidemiology and clinical characteristics of Crohn's disease in the Asia-Pacific region?

Sinwon Lee, Byong Duk Ye

Intest Res. 2016;14(1):2-4.

Pneumoperitoneum After Percutaneous Endoscopic Gastrostomy: Does It Have Clinical Significance?

Ju Yup Lee, Kyung Sik Park

Intest Res. 2015;13(4):295-296.

Is Long-Term Therapy With Thiopurines Effective for Maintaining Remission in Patients With Moderate-To-Severe Ulcerative Colitis?

Seong Ran Jeon, Won Ho Kim

Intest Res. 2015;13(3):191-192.

Are Small Rectal Neuroendocrine Tumors Safe?

Jae Ho Choi, Jae Myung Cha

Intest Res. 2015;13(2):103-104.

Application of Endoscopic Ultrasonography in the Diagnosis and Treatment of Lower Gastrointestinal Disease

Eun Young Kim

Intest Res. 2015;13(2):101-102.

The Positive Influences of Increasing Age at Diagnosis of Inflammatory Bowel Disease on Disease Prognostication in Asian Perspective

Raja Affendi Raja Ali

Intest Res. 2015;13(1):4-5.

A Clinical Significance of Assessing Cytomegalovirus Infection Status in Patients With Ulcerative Colitis

Sooyun Chang, Jae Hee Cheon

Intest Res. 2015;13(1):2-3.

Risk Factors for Delayed Recurrence of Clostridium difficile Infection

Ji Won Kim

Intest Res. 2014;12(4):266-267.

Could Early Anti-Tumor Necrosis Factor Therapy Change the Prognosis of Crohn's Disease?

Byong Duk Ye

Intest Res. 2014;12(4):263-265.

A High Risk Group in the Modified National Institutes of Health Consensus Criteria for the Gastrointestinal Stromal Tumor: A Clear Indication of the Adjuvant Imatinib

Dong Kyung Chang

Intest Res. 2014;12(3):176-177.

Clinicopathological Characteristics of Newly Diagnosed Colorectal Cancers in Community Gastroenterology Practice

Chang Kyun Lee

Intest Res. 2014;12(2):87-89.